Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Melarsoprol

EU orphan designation number: EU/3/12/1068   
Active ingredient: Melarsoprol
Indication: Treatment of African trypanosomiasis
Sponsor: Stéphane Gibaud
Université de Lorraine, Faculté de Pharmacie, 7 avenue de la Fôret de Haye, BP 90170, 54505 Vandœuvre-lès-Nancy, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/11/2012 Orphan designation EMA/OD/116/12 (2012)8202 of 8/11/2012
1/02/2019 Transfer of orphan designation EMA/OD/0000003439 (2019)813 of 30/01/2019